Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-02-20 @ 4:43 PM
Study NCT ID:
NCT05260957
Status:
RECRUITING
Last Update Posted:
2024-12-19
First Post:
2022-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
Sponsor:
Lazaros Lekakis
Organization: